2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
21
Breast Neoplasms
20
Neoplasms
19
Stomach Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Endometrial Neoplasms
13
Pancreatic Neoplasms
11
Leukemia, Myeloid, Acute
10
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Oropharyngeal Neoplasms
6
Neoplasm Metastasis
6
Multiple Myeloma
6
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Sarcoma
5
Rectal Neoplasms
5
Mouth Neoplasms
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Head and Neck Neoplasms
5
Uterine Cervical Neoplasms
4
Recurrence
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, Mantle-Cell
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Interventions
Cisplatin
16
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Radiotherapy
7
Docetaxel
7
Fluorouracil
5
Erlotinib Hydrochloride
5
Everolimus
4
Carboplatin
4
Sorafenib
3
Radiation
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Chemotherapy, Adjuvant
3
Biopsy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
Ultrasonography
2
Taxes
2
Sirolimus
2
Radiotherapy, Conformal
2
Psychiatric Rehabilitation
2
Platinum
2
Photochemotherapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Gene Expression Profiling
2
Drug Therapy
2
Cryosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tongue Neoplasms
×
Observation
×
Clear all
NCT02748707
2022-04-28
ERLO-XIB
Tata Memorial Hospital
Phase 2
Unknown
64 enrolled